CurrentPartnering

Established in 2007, CurrentPartnering is a company, publishing deal terms and business development best practice reports, which offer access to business intelligence data and description of the recent and emerging trends in the partnering activity across a broad range of the life sciences industries. CurrentPartnering helps their clients to get ready for negotiations and gain better understanding of the potential deal structures available to them.

The list of CurrentPartnering’s customers is represented by numerous bigpharma, diagnostics, pharmaceutical and biotech companies. The reports published by CurrentPrartnering deliver to their clients assessment of potential partnerships terms, in-depth insights into the major financial terms and other key issues essential for successful partnering. CurrentPartnering supplies its customers with cutting-edge information required to optimize their partnering activities.

Research Reports By CurrentPartnering

Found 378 publications
Head and Neck Cancer Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Nutrition and Vitamin Partnering 2009-2014 US$ 1,795.00 US$ 1,436.00 Nov, 2014 250 pages
Cangene Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Colorectal Cancer Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 150 pages
Biocon Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Merck KGaA / Merck Serono Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Liver Disease Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Pharmacyclics Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Abbvie Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Valeant Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Alnylam Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Actavis Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Stroke Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 150 pages
Gastrointestinal Symptoms Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Tropical Disease Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Optimer Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Smoking Cessation Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Pain Partnering 2009-2014 US$ 1,995.00 US$ 1,596.00 Nov, 2014 250 pages
Inflammatory Bowel Disease Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
MRSA Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Asthma Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Herpes simplex Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Viropharma Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Epilepsy Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Anxiety Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Menopause Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
E.coli Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Glaucoma Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Spectrum Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Cystic Fibrosis Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Questcor Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Arrhythmia Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
GlaxoSmithKline Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Blood Substitute Partnering 2009-2014 US$ 695.00 Nov, 2014 150 pages
Forest Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Arthritis Partnering 2009-2014 US$ 695.00 Nov, 2014 250 pages
Dainippon Sumitomo Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Warner Chilcott Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Peripheral Arterial Disease Partnering 2009-2014 US$ 695.00 Nov, 2014 100 pages
Celgene Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
NPS Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Hypertension Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Baxter Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Immunomedics Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Pancreatic Cancer Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 150 pages
Shire Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Syngenta Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Purdue Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Essilor Pharmaceuticals Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
Amgen Partnering 2009-2014 US$ 995.00 US$ 796.00 Nov, 2014 100 pages
1 2 3 4 5 ... 8
Skip to top

News & Press-Releases by CurrentPartnering